187 related articles for article (PubMed ID: 26235642)
41. In situ DOX-calcium phosphate mineralized CPT-amphiphilic gelatin nanoparticle for intracellular controlled sequential release of multiple drugs.
Li WM; Su CW; Chen YW; Chen SY
Acta Biomater; 2015 Mar; 15():191-9. PubMed ID: 25542535
[TBL] [Abstract][Full Text] [Related]
42. Cytochrome c conjugated to ZnO-MAA nanoparticles: the study of interaction and influence on protein structure.
Simšíková M; Antalík M; Kaňuchová M; Skvarla J
Int J Biol Macromol; 2013 Aug; 59():235-41. PubMed ID: 23628581
[TBL] [Abstract][Full Text] [Related]
43. Cytochrome C encapsulating theranostic nanoparticles: a novel bifunctional system for targeted delivery of therapeutic membrane-impermeable proteins to tumors and imaging of cancer therapy.
Santra S; Kaittanis C; Perez JM
Mol Pharm; 2010 Aug; 7(4):1209-22. PubMed ID: 20536259
[TBL] [Abstract][Full Text] [Related]
44. Rapid preparation of pH-sensitive polymeric nanoparticle with high loading capacity using electrospray for oral drug delivery.
Hao S; Wang Y; Wang B; Deng J; Liu X; Liu J
Mater Sci Eng C Mater Biol Appl; 2013 Dec; 33(8):4562-7. PubMed ID: 24094160
[TBL] [Abstract][Full Text] [Related]
45. In situ forming reduction-sensitive degradable nanogels for facile loading and triggered intracellular release of proteins.
Chen W; Zheng M; Meng F; Cheng R; Deng C; Feijen J; Zhong Z
Biomacromolecules; 2013 Apr; 14(4):1214-22. PubMed ID: 23477570
[TBL] [Abstract][Full Text] [Related]
46. Synthetic 1,4-anthracenedione analogs induce cytochrome c release, caspase-9, -3, and -8 activities, poly(ADP-ribose) polymerase-1 cleavage and internucleosomal DNA fragmentation in HL-60 cells by a mechanism which involves caspase-2 activation but not Fas signaling.
Perchellet EM; Wang Y; Weber RL; Sperfslage BJ; Lou K; Crossland J; Hua DH; Perchellet JP
Biochem Pharmacol; 2004 Feb; 67(3):523-37. PubMed ID: 15037204
[TBL] [Abstract][Full Text] [Related]
47. Polyhydroxybutyrate-coated magnetic nanoparticles for doxorubicin delivery: cytotoxic effect against doxorubicin-resistant breast cancer cell line.
Yalcin S; Unsoy G; Mutlu P; Khodadust R; Gunduz U
Am J Ther; 2014; 21(6):453-61. PubMed ID: 25137407
[TBL] [Abstract][Full Text] [Related]
48. On-chip fabrication of calcium carbonate nanoparticles loaded with various compounds using microfluidic approach.
Arabuli KV; Kopoleva E; Akenoun A; Mikhailova LV; Petrova E; Muslimov AR; Senichkina DA; Tsymbal S; Shakirova AI; Ignatiev AI; Lepik KV; Zyuzin MV
Biomater Adv; 2024 Jul; 161():213904. PubMed ID: 38805763
[TBL] [Abstract][Full Text] [Related]
49. Novel cyclodextrin nanosponges for delivery of calcium in hyperphosphatemia.
Shende P; Deshmukh K; Trotta F; Caldera F
Int J Pharm; 2013 Nov; 456(1):95-100. PubMed ID: 23954237
[TBL] [Abstract][Full Text] [Related]
50. Monodispersed calcium carbonate nanoparticles modulate local pH and inhibit tumor growth in vivo.
Som A; Raliya R; Tian L; Akers W; Ippolito JE; Singamaneni S; Biswas P; Achilefu S
Nanoscale; 2016 Jul; 8(25):12639-47. PubMed ID: 26745389
[TBL] [Abstract][Full Text] [Related]
51. Unfolding of cytochrome C upon interaction with azobenzene-modified copolymers.
Sun J; Ruchmann J; Pallier A; Jullien L; Desmadril M; Tribet C
Biomacromolecules; 2012 Nov; 13(11):3736-46. PubMed ID: 23005031
[TBL] [Abstract][Full Text] [Related]
52. Glyco-nanoparticles with sheddable saccharide shells: a unique and potent platform for hepatoma-targeting delivery of anticancer drugs.
Chen W; Zou Y; Meng F; Cheng R; Deng C; Feijen J; Zhong Z
Biomacromolecules; 2014 Mar; 15(3):900-7. PubMed ID: 24460130
[TBL] [Abstract][Full Text] [Related]
53. In vitro ultrastructural changes of MCF-7 for metastasise bone cancer and induction of apoptosis via mitochondrial cytochrome C released by CaCO3/Dox nanocrystals.
Kamba AS; Ismail M; Ibrahim TA; Zakaria ZA; Gusau LH
Biomed Res Int; 2014; 2014():391869. PubMed ID: 25028650
[TBL] [Abstract][Full Text] [Related]
54. Mesoporous silica nanoparticles for intracellular delivery of membrane-impermeable proteins.
Slowing II; Trewyn BG; Lin VS
J Am Chem Soc; 2007 Jul; 129(28):8845-9. PubMed ID: 17589996
[TBL] [Abstract][Full Text] [Related]
55. Impact of Choline Hydroxide-Supported Magnetic Nanoparticles on Peroxidase Activity and Conformational Stability of Cytochrome c.
Chahar D; Jha I; Arumugam J; Venkatesu P
ACS Appl Bio Mater; 2024 Feb; 7(2):1135-1145. PubMed ID: 38262058
[TBL] [Abstract][Full Text] [Related]
56. Novel free-paclitaxel-loaded redox-responsive nanoparticles based on a disulfide-linked poly(ethylene glycol)-drug conjugate for intracellular drug delivery: synthesis, characterization, and antitumor activity in vitro and in vivo.
Chuan X; Song Q; Lin J; Chen X; Zhang H; Dai W; He B; Wang X; Zhang Q
Mol Pharm; 2014 Oct; 11(10):3656-70. PubMed ID: 25208098
[TBL] [Abstract][Full Text] [Related]
57. Strategic formulation of apigenin-loaded PLGA nanoparticles for intracellular trafficking, DNA targeting and improved therapeutic effects in skin melanoma in vitro.
Das S; Das J; Samadder A; Paul A; Khuda-Bukhsh AR
Toxicol Lett; 2013 Nov; 223(2):124-38. PubMed ID: 24070738
[TBL] [Abstract][Full Text] [Related]
58. PUA/PSS multilayer coated CaCO3 microparticles as smart drug delivery vehicles.
Du C; Shi J; Shi J; Zhang L; Cao S
Mater Sci Eng C Mater Biol Appl; 2013 Oct; 33(7):3745-52. PubMed ID: 23910272
[TBL] [Abstract][Full Text] [Related]
59. Interaction of cytochrome c with zinc oxide nanoparticles.
Šimšíková M; Antalík M
Colloids Surf B Biointerfaces; 2013 Mar; 103():630-4. PubMed ID: 23274157
[TBL] [Abstract][Full Text] [Related]
60. Enhanced combination cancer therapy using lipid-calcium carbonate/phosphate nanoparticles as a targeted delivery platform.
Wu Y; Gu W; Xu ZP
Nanomedicine (Lond); 2019 Jan; 14(1):77-92. PubMed ID: 30543136
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
